Get the content you want anytime you want.
REGISTER NOW | SIGN IN
The Best Infectious Disease News Delivered Weekly

The Contagion® Prevention specialty page provides infection prevention-specific clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

PREVENTION NEWS - Page 1

Improving Care for Criminalized Populations at Risk for HIV in Botswana
Several key populations with heightened risk for HIV face criminalization in Botswana. The Botswana Family Welfare Association targeted efforts to improve care for these key populations.
Survey Reveals Beliefs About Transgender Clients Among Nursing Students
An educational research study reveals positive attitudes and a willingness to provide care among pre-licensure Bachelor of Science nursing students.
Exploring the Experiences of Young Adults with Perinatally Acquired HIV
A new study examined young adults with perinatally acquired HIV living in South Florida in order to shed light on their lived experiences.
“My story is important only because it proves that HIV can be cured. And if something has happened, once in medical science, it can happen again,” Brown told Contagion®.
PrEP
Neither infectious disease specialists nor primary care providers appear to consider PrEP care to fall within their practice, and similar debates have taken place between nurses and physicians.
 
NYC Health + Hospitals Celebrates 5 Years of Special Pathogens Preparedness
Since 2014 NYC Health + Hospitals has worked to maintain preparedness against diseases like Ebola. 
FDA Approves Fluzone High-Dose Quadrivalent Influenza Vaccine for Older Adults
Fluzone High-Dose Quadrivalent is given to people 65 years of age and older to help prevent influenza disease caused by influenza A and B strains contained in the vaccine.
Neuraminidase Protein Could be a Target for New Influenza Treatments and Vaccines
While most influenza vaccines target the binding protein hemagglutinin, a new study shows cross-strain results for treatment and prevention focused on the glycoprotein neuraminidase.
FEATURED
Is there a cure? How long until we find it? And will it work for the majority of people living with HIV?